- Home
- OABI vs POET Comparison
OABI vs POET Comparison
Compare OABI & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- POET
- Stock Information
- Founded
- OABI 2012
- POET 1972
- Country
- OABI United States
- POET Canada
- Employees
- OABI N/A
- POET N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- OABI Health Care
- POET Technology
- Exchange
- OABI Nasdaq
- POET Nasdaq
- Market Cap
- OABI 307.4M
- POET 275.1M
- IPO Year
- OABI N/A
- POET N/A
- Fundamental
- Price
- OABI $2.28
- POET $3.67
- Analyst Decision
- OABI Strong Buy
- POET Strong Buy
- Analyst Count
- OABI 3
- POET 2
- Target Price
- OABI $7.00
- POET $6.25
- AVG Volume (30 Days)
- OABI 780.2K
- POET 1.1M
- Earning Date
- OABI 03-18-2025
- POET 05-14-2025
- Dividend Yield
- OABI N/A
- POET N/A
- EPS Growth
- OABI N/A
- POET N/A
- EPS
- OABI N/A
- POET N/A
- Revenue
- OABI $26,391,000.00
- POET $41,427.00
- Revenue This Year
- OABI $77.72
- POET N/A
- Revenue Next Year
- OABI $30.95
- POET $7,600.00
- P/E Ratio
- OABI N/A
- POET N/A
- Revenue Growth
- OABI N/A
- POET N/A
- 52 Week Low
- OABI $2.23
- POET $1.00
- 52 Week High
- OABI $5.54
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- OABI 27.98
- POET 42.39
- Support Level
- OABI $2.38
- POET $3.89
- Resistance Level
- OABI $2.57
- POET $4.57
- Average True Range (ATR)
- OABI 0.18
- POET 0.30
- MACD
- OABI -0.04
- POET 0.02
- Stochastic Oscillator
- OABI 4.42
- POET 17.64
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.